risk
group
pathogen
group
often
lethal
human
virus
wide
avail
vaccin
therapeut
virus
endem
specif
geograph
locat
typic
caus
rel
infrequ
world
health
organ
risk
group
rg
pathogen
rel
small
group
highconsequ
viral
pathogen
caus
seriou
lifethreaten
diseas
human
anim
effect
medic
countermeasur
mcm
usual
avail
handl
replic
form
pathogen
typic
requir
maximum
biosafeti
level
contain
facil
tabl
around
three
dozen
global
notori
exampl
pathogen
includ
virus
associ
acut
diseas
outbreak
ebola
viru
ebov
recent
caus
human
diseas
outbreak
western
africa
encompass
case
death
lassa
viru
infect
peopl
nigeria
virus
caus
tempor
isol
small
case
cluster
kyasanur
forest
diseas
viru
human
infect
sever
virus
consid
potenti
sourc
materi
develop
biolog
weapon
therefor
consid
research
prioriti
within
nation
public
health
biodefens
program
acceler
increasingli
focus
effort
develop
mcm
prevent
andor
treatment
pathogen
undertaken
allevi
potenti
commun
suffer
associ
socioeconom
impact
research
pathogen
gener
involv
cell
cultur
method
vitro
live
virus
surrog
system
eg
minigenom
virionlik
particl
recombin
express
individu
viral
protein
virion
pseudotyp
andor
anim
model
vivo
investig
viral
pathogenesi
host
respons
infect
cell
cultur
use
simpl
tool
research
specif
aspect
viral
infect
screen
candid
therapeut
antivir
activ
quantifi
host
immun
respons
virusneutr
antibodi
titer
howev
current
common
cell
cultur
method
model
complex
bodi
system
anim
model
rodent
nonhuman
primat
gener
use
model
diseas
next
increas
secur
measur
prevent
unauthor
entri
agent
misus
theft
laboratori
multipl
layer
redund
safeti
precaut
includ
positivepressur
suit
class
iii
biolog
safeti
cabinet
valid
method
inactiv
pathogen
protect
laboratori
worker
accident
potenti
lethal
infect
enhanc
regulatori
biosafeti
environ
encumb
research
physic
limit
talent
pool
research
permit
work
facil
therefor
technolog
advanc
pathogen
research
becom
especi
import
maxim
data
output
lessen
time
requir
research
addit
research
perform
field
laboratori
outbreak
virusendem
zone
permiss
intern
review
board
affect
countri
provid
import
insight
diseas
cours
associ
human
pathogen
infect
monitor
patient
refin
pathogen
key
event
includ
serum
chemic
hematolog
valu
aberr
diseas
therebi
provid
guidanc
clinician
research
diseas
progress
diseas
model
develop
respect
research
focus
mcm
test
pathogen
occasion
shown
consider
promis
clinic
trial
ring
vaccin
howev
pathogen
diseas
outbreak
often
occur
underdevelop
countri
andor
geograph
remot
area
research
hamper
limit
access
resourc
transport
skill
local
technician
pool
reason
advanc
research
tool
simplif
test
methodolog
could
help
allevi
challeng
associ
perform
research
advanc
imag
modal
comput
tomographi
ct
magnet
reson
imag
mri
positron
emiss
tomographi
pet
singl
photon
emiss
comput
tomographi
spect
ultrasound
us
develop
one
activ
facil
studi
immun
host
system
respons
infect
pathogen
imag
advantag
noninvas
detect
sign
infecti
diseas
earlier
timepoint
clinic
sign
alon
find
qualit
radiolog
report
quantifi
accord
standard
method
includ
longitudin
imag
registr
organles
segment
measur
morpholog
physiolog
chang
due
diseas
howev
quantit
method
often
requir
time
consum
manual
trace
region
interest
trace
subject
therefor
develop
autom
method
need
decreas
time
requir
reduc
variabl
increas
accuraci
method
horizon
instanc
artifici
intellig
ai
consider
promis
advanc
medic
imag
field
ai
algorithm
learn
data
unsupervis
supervis
eg
deep
learn
latter
algorithm
train
prior
use
larg
pool
data
howev
imag
data
alon
suffici
train
supervis
deep
learn
algorithm
neural
network
imag
data
must
label
eg
pneumonia
vs
normal
xray
lesion
vs
normal
tissu
proper
algorithm
identif
label
process
often
quit
timeconsum
prone
human
error
avoid
error
anoth
field
ai
natur
languag
process
util
textbas
report
gener
radiologist
associ
find
imag
train
deep
learn
algorithm
altern
quantiti
data
insuffici
train
ai
algorithm
data
augment
method
rotat
horizont
flip
random
crop
perform
addit
neural
network
architectur
call
gener
adversari
network
gan
use
gener
synthet
imag
acquisit
adequ
train
data
patholog
imag
phenotyp
challeng
oneclass
classif
neural
network
develop
train
normal
imag
detect
abnorm
imag
type
deep
learn
neural
network
call
convolut
neural
network
integr
imag
featur
extract
within
artifici
neural
network
contain
mani
hidden
layer
classifi
segment
imag
deep
learn
neural
network
design
variou
way
current
googlenet
inceptionresnet
popular
architectur
imag
classif
wherea
unet
vnet
popular
architectur
imag
segment
one
activ
facil
medic
imag
perform
pathogeninfect
anim
within
contain
wherea
ai
yet
use
analyz
avail
imag
modal
unsupervis
ai
algorithm
call
fuzzi
cmean
cluster
alreadi
util
mri
segment
brain
tissu
grey
matter
white
matter
cerebrospin
fluid
combin
digit
brain
atla
registr
brain
robustli
segment
multipl
subregion
coloc
longitudin
scan
fig
mr
imag
compos
threedimension
grid
voxel
assign
signal
valu
throughout
imag
sinc
voxel
valu
mri
scan
arbitrari
unit
unlik
ct
scan
character
pixel
valu
directli
proport
densiti
imag
tissu
parametr
map
assign
quantiti
voxel
creat
multipl
mri
sequenc
parametr
map
provid
imag
exampl
form
relaxometri
map
physic
quantiti
repres
relax
proton
spin
tissu
chang
tissu
composit
exampl
brain
edema
result
viral
infect
valu
increas
due
addit
fluid
tissu
region
delin
fuzzi
cmean
cluster
atlasbas
registr
directli
appli
parametr
map
chang
diseas
statu
accumul
fluid
blood
brain
predict
abnorm
find
mri
brain
experiment
anim
like
except
use
refin
sequenc
pathogenet
event
diseas
caus
encephalit
pathogen
hendra
viru
nipah
viru
tickborn
enceph
viru
exampl
brain
mri
scan
patient
infect
nipah
viru
shown
acut
enceph
multipl
lesion
visibl
use
fluid
attenu
invers
recoveri
flair
imag
mr
imag
sequenc
perform
human
studi
may
perform
refin
anim
model
use
clinic
mr
scanner
within
environ
mani
pathogen
diffus
affect
multipl
organ
within
human
bodi
includ
lung
abnorm
caus
nipah
viru
infect
liver
damag
dissemin
intravascular
coagulopathi
ebov
infect
therefor
segment
liver
kidney
spleen
lung
lymph
node
collect
imag
need
detect
structur
physiolog
chang
deep
learn
convolut
neural
network
automat
segment
multipl
abdomin
organ
ct
mri
modal
use
process
describ
given
robust
segment
radiometr
featur
textur
histogram
analysi
voxel
within
region
interest
use
classifi
stage
diseas
process
correl
featur
clinic
paramet
liver
enzym
concentr
viru
titer
instanc
method
quantifi
lung
abnorm
variou
diseas
model
avail
initi
lung
automat
segment
chest
ct
scan
segment
lung
field
without
patholog
condit
done
standard
imag
analysi
method
region
grow
start
initi
seed
point
within
region
interest
includ
area
vicin
seed
point
base
whether
signal
intens
within
given
threshold
iter
process
end
valu
neighbor
voxel
within
threshold
howev
region
grow
algorithm
fail
initi
lung
segment
hyperdens
voxel
lung
outsid
threshold
requir
manual
correct
recent
ai
method
establish
fulli
autom
lung
field
segment
process
lung
contain
hyperdens
patholog
area
deep
learn
algorithm
train
thousand
normal
abnorm
human
ct
lung
imag
segment
imag
lung
field
postprocess
morpholog
oper
eros
remov
area
dilat
inclus
area
need
final
segment
process
modifi
postprocess
paramet
accur
lung
field
segment
achiev
nonhuman
primat
fig
wherea
lung
field
origin
overestim
current
method
analys
also
involv
correl
imag
biomark
clinic
measur
cytokin
profil
viral
dnarna
concentr
blood
composit
test
futur
ai
method
could
appli
integr
collect
imag
clinic
data
gener
predict
model
diseas
outcom
machinelearn
featur
imag
may
use
predict
abnorm
statu
prior
clinic
manifest
abnorm
even
though
may
visibl
human
eye
integr
imag
nonimag
measur
may
predict
surviv
efficaci
novel
vaccin
therapi
molecular
imag
use
gain
understand
cellular
molecular
statu
compar
anatom
imag
standard
ct
mri
provid
structur
inform
larger
scale
molecular
probe
fluorodeoxyglucos
ffdg
marker
cellular
glycolyt
activ
indic
increas
cell
metabol
activ
organ
infect
pathogen
unfortun
probe
ffdg
entir
specif
develop
agentdiseasespecif
probe
urgent
need
exampl
specif
probe
investig
studi
host
respons
infecti
diseas
imag
includ
pet
fluorin
radioisotop
fluorothymidin
fflt
radiolabel
serum
albumin
falbumin
fflt
use
investig
cellular
prolifer
cancer
lymphoma
infecti
diseas
falbumin
use
detect
vessel
leakag
select
ligand
transloc
protein
tspo
investig
overexpress
activ
macrophag
serv
biomark
neuroinflamm
marker
could
prove
use
studi
contour
lung
field
segment
deep
learn
algorithm
train
human
ct
scan
lung
field
overestim
c
contour
nonhuman
primat
lung
field
accur
segment
modif
postprocess
method
accur
segment
nonhuman
primat
lung
field
ct
scan
appar
lung
abnorm
diseas
caus
pathogen
ebola
viru
macrophag
activ
increas
vessel
leakag
key
pathogen
event
ebola
viru
diseas
contrast
hostspecif
probe
mention
probe
attach
virion
reporterencod
open
read
frame
insert
pathogen
genom
could
directli
local
viru
specif
area
bodi
develop
report
virus
begun
instanc
gene
encod
solut
carrier
famili
member
aka
sodiumiodid
symport
insert
middl
eastern
respiratori
syndrom
coronaviru
genom
pathogen
result
viabl
viru
futur
imag
report
could
incorpor
varieti
viral
vector
obtain
vivo
visual
locat
aid
evalu
vaccin
therapeut
develop
howev
major
hurdl
overcom
viru
attenu
report
gene
insert
systemwid
respons
requir
overcom
exposur
pathogen
involv
complex
interact
resid
tissu
cell
infiltr
immun
cell
yet
identif
specif
cell
type
tissu
section
hinder
limit
tradit
immunofluoresc
spectral
overlap
fluorophor
typic
restrict
immunofluoresc
studi
maximum
around
four
antibodi
channel
therebi
preclud
simultan
identif
multipl
highli
special
cell
type
invad
pathogen
singl
tissu
section
though
develop
multipl
multiplex
imag
modal
vital
overcom
limit
focu
new
advanc
patholog
imag
new
techniqu
call
codetect
index
codex
bypass
limit
immunofluoresc
antibodi
channel
use
antibodi
label
index
dna
tag
technolog
cocktail
upward
dnaindex
antibodi
stain
tissu
section
prior
iter
fluoresc
visual
cycl
assembl
singl
paramet
imag
codex
highli
effect
multiplex
techniqu
singl
antibodi
bind
step
elimin
much
signal
degrad
would
otherwis
associ
strip
restain
antibodi
commerci
avail
codex
instrument
automat
exchang
buffer
need
accomplish
iter
imag
cycl
instrument
rel
small
footprint
may
practic
use
insid
contain
optim
reagent
use
inactiv
sampl
pathogen
studi
anoth
techniqu
call
multiplex
ion
beam
imag
mibi
util
secondari
ion
mass
spectrometri
gener
highdimension
imag
mass
spectrometri
analysi
lanthanidelabel
antibodi
pixelbypixel
level
commerci
avail
technolog
thu
far
leverag
deep
spatial
understand
archiv
breast
cancer
tissu
key
featur
metaltag
tissu
imag
highli
stabl
natur
isotop
label
sampl
archiv
theoret
indefinit
instanc
allow
reacquisit
target
sampl
region
analysi
reimag
higher
resolut
instrument
year
later
mibi
workflow
inactiv
tissu
eg
formalinfix
paraffinembed
ffpe
process
follow
convent
immunohistochemistri
ihc
protocol
except
antibodi
cocktail
routin
tissu
stain
consist
lanthanidetag
antibodi
compar
convent
one
two
antibodi
ihc
parallel
method
term
imag
mass
cytometri
imc
util
laser
ablat
coupl
cytometri
time
flight
cytof
mass
cytomet
also
commerci
avail
antibodi
reagent
sampl
prepar
mostli
crosscompat
current
method
detect
pathogen
tissu
divid
antibodybas
detect
nucleic
acid
na
base
detect
antibodybas
method
ihc
sever
limit
avail
specif
antibodi
clone
conserv
target
epitop
although
nabas
method
situ
hybrid
ish
ideal
identif
sequencespecif
target
method
also
disadvantag
necessari
signal
amplif
target
challeng
experiment
protocol
complex
probe
design
achiev
specif
sensit
disadvantag
larg
circumv
develop
next
gener
ish
method
probe
design
softwar
rnascop
exampl
nextgener
ish
success
implement
detect
virus
eg
marv
ebov
rnascop
also
use
follow
singleintegr
event
simian
immunodefici
viru
tissu
demonstr
sensit
technolog
altern
enzymaticbas
virusspecif
ish
also
adapt
surveil
hepat
delta
viru
current
rnascop
method
demonstr
abil
work
imc
detect
highli
abund
copi
rna
ffpe
tissu
howev
even
advanc
technolog
ihcand
ishbas
method
continu
suffer
limit
number
marker
examin
simultan
even
combin
futur
work
coupl
multiplex
imag
techniqu
eg
imc
mibi
codex
sensit
ish
technolog
instrument
mechanist
dissect
virusinfect
cell
context
tissu
microenviron
viral
reservoir
broader
environ
coupl
increas
understand
dynam
viral
infect
replic
pathogen
studi
wherea
current
futurist
technolog
describ
earlier
use
target
imag
tissu
section
section
tissu
make
difficult
unbiasedli
investig
pathogen
distribut
effect
infect
organ
whole
section
requir
howev
mammalian
tissu
natur
opaqu
imped
imag
deeper
tissu
hundr
micromet
combat
limit
research
begun
develop
chemic
method
render
tissu
transpar
tissu
clear
includ
entir
adult
mous
bodi
follow
skin
remov
imag
transpar
tissu
optic
exampl
tissu
clear
use
combin
antibodi
signalboost
techniqu
produc
highresolut
neuron
project
map
adult
mous
brain
addit
techniqu
use
conjunct
detect
cancer
metastas
transpar
mous
assess
therapeut
antibodi
target
cancer
cell
singlecel
level
though
yet
realiz
pathogen
research
use
combin
tissu
clear
optic
imag
could
use
investig
pathogen
infect
host
respons
treatment
efficaci
optic
report
fluoresc
protein
insert
pathogen
genom
optic
label
antibodi
system
bind
pathogen
specif
immun
cell
eg
antibodi
flow
cytometri
use
investig
pathogen
immun
cell
distribut
throughout
host
vari
timepoint
diseas
addit
treatment
efficaci
could
assess
pathogen
similarli
cancer
treatment
assess
describ
previous
flow
cytometri
analysi
singl
cell
solut
cornerston
advanc
understand
immun
respons
infect
past
decad
howev
spectral
overlap
fluoresc
markertag
antibodi
use
flow
cytometri
limit
simultan
examin
larg
number
cellular
featur
replac
fluoresc
tag
metal
ion
antibodi
tag
enabl
develop
cytof
overcom
tradit
multiplex
limit
blood
dissoci
cell
profil
cytof
appli
monitor
immun
respons
diseas
vaccin
expand
multiplex
capabl
singlecel
measur
offer
exponenti
return
profil
complex
immun
cell
wherea
flow
cytometri
rare
perform
paramet
limit
analysi
subset
cell
type
signal
readout
cytof
comfort
identifi
paramet
singl
cell
singl
antibodi
panel
identifi
major
immun
cell
subset
blood
sampl
addit
quantifi
activ
statu
cytokin
product
signal
state
cell
type
case
pathogen
studi
sampl
volum
frequent
limit
suppli
either
sourc
rare
human
diseas
outbreak
rel
experiment
infect
anim
limit
number
facil
fring
benefit
highli
multiplex
technolog
includ
cytof
small
sampl
produc
greater
number
measur
evalu
hypothes
simultan
instanc
gap
exist
experiment
clinic
data
pathogen
might
narrow
care
plan
cytof
studi
rare
patient
sampl
examin
simultan
multipl
cellular
featur
observ
experiment
model
dividend
cytof
shed
light
infecti
diseas
underscor
find
number
recent
studi
use
cytof
yet
realiz
pathogen
research
one
challeng
use
cytof
studi
current
unsuit
design
compon
cytof
instrument
oper
insid
maximum
contain
environ
compress
ga
highvolum
exhaust
requir
glasswar
superh
compon
address
challeng
workflow
current
develop
enabl
cytof
analysi
virusinactiv
sampl
deriv
pathogen
studi
set
cytof
reagent
direct
comparison
immun
system
respons
human
laboratori
mice
nonhuman
primat
anim
model
frequent
use
pathogen
research
alreadi
avail
similar
reagent
consid
develop
guinea
pig
hamster
ferret
model
expand
toolset
like
contribut
toward
framework
futur
indepth
pathogen
studi
across
differ
anim
speci
therebi
also
inform
choic
anim
model
use
diverg
scientif
question
cytof
singlecel
sequenc
highdimension
imag
yield
larg
dataset
timeconsum
analyz
exhaust
gener
analysi
principl
appli
dataset
partit
cell
phenotyp
subsequ
analysi
function
behavior
andor
relationship
larg
number
tool
develop
adapt
field
perform
task
autom
semiautom
fashion
pathogen
research
key
benefit
comput
tool
multiparamet
singlecel
data
possibl
identifi
biomark
consist
unanticip
combin
paramet
would
miss
manual
approach
eg
gate
cytometri
data
mani
case
tool
use
cytof
directli
appli
segment
singlecel
data
multiparamet
imag
howev
addit
spatial
posit
multiplex
singlecel
data
creat
imag
result
enorm
higher
depth
inform
tool
address
structur
cellular
neighborhood
within
tissu
impact
health
diseas
develop
widespread
adopt
nextgener
sequenc
ng
revolution
virtual
everi
facet
molecular
biolog
human
health
includ
studi
pathogen
determin
first
human
genom
sequenc
took
decad
perform
predominantli
sanger
technolog
sinc
ng
instrument
blossom
ng
data
output
grow
exponenti
everi
year
gener
billion
read
singl
sequenc
run
possibl
current
avail
ng
platform
advantag
disadvantag
larg
sequenc
center
regularli
gener
singl
human
genom
sequenc
everi
minut
use
mani
platform
contrast
sanger
method
ng
sequenc
million
dna
strand
singlemolecul
level
also
allow
research
obtain
accur
sequenc
inform
smaller
genom
pathogen
futur
extens
catalogu
human
pathogen
genom
variat
provid
better
insight
hostpathogen
interact
therebi
enabl
person
medicin
approach
even
exot
diseas
outbreak
research
studi
human
biolog
devis
upstream
workflow
take
advantag
abil
ng
sequenc
million
read
mine
data
answer
new
scientif
question
seek
studi
pathogen
leverag
ngsbase
assay
though
replicationcompet
pathogen
must
handl
facil
ng
protocol
perform
lower
bsl
eg
sampl
appropri
inactiv
nucleic
acid
na
extract
plethora
ng
applic
describ
three
broad
categori
ngsbase
assay
see
section
detect
unknown
na
see
section
mark
unknown
featur
na
structur
modifi
base
map
locat
see
section
quantifi
biomolecul
sampl
see
section
metagenom
ng
mng
power
tool
identifi
pathogen
clinic
environment
sampl
diseas
caus
mani
pathogen
gener
challeng
diagnos
patient
diseas
often
present
nonspecif
influenzalik
clinic
sign
even
highli
replic
virus
typic
compris
minor
na
sampl
rather
test
everi
pathogen
individu
scientist
use
mng
sequenc
million
molecul
na
sampl
reveal
low
frequenc
na
pathogen
nonpathogen
organ
supplement
method
manipul
na
enhanc
sensit
costeffect
mng
includ
multiplex
polymeras
chain
reaction
pcr
hybrid
captur
cluster
regularli
interspac
short
palindrom
repeat
crispr
base
method
way
current
possibl
biomolecul
like
protein
lipid
recent
use
mng
pathogen
includ
analyz
sequenc
ebola
viru
diseas
evd
epidem
western
africa
two
recent
evd
outbreak
democrat
republ
congo
recent
lassa
fever
outbreak
nigeria
case
multipl
research
group
collabor
african
partner
collect
clinic
sampl
inactiv
guanidiniumbas
reagent
extract
viral
rna
revers
transcrib
rna
cdna
sequenc
mng
case
specif
causal
pathogen
suspect
possibl
perform
multiplex
pcr
enrich
concentr
ebov
lasv
content
sequenc
univers
serial
bu
usb
size
oxford
nanopor
minion
devic
field
contrast
group
use
nontarget
amplif
method
reveal
intrigu
coinfect
dynam
pathogen
interest
pathogen
would
normal
remov
enrich
process
eg
ebov
plasmodium
ebov
gb
viru
c
decis
appropri
public
health
respons
also
greatli
inform
collect
catalogu
hundr
thousand
viral
genom
sequenc
outbreak
molecular
epidemiolog
ie
use
viral
sequenc
data
identifi
diseas
transmiss
chain
provid
key
insight
outbreak
inform
animaltohuman
humantohuman
transmiss
instanc
suspect
super
spread
transmiss
persist
infect
diseas
survivor
sequenc
data
also
inform
model
factor
influenc
outbreak
scale
sever
andor
viral
evolutionari
rate
facilit
identif
high
frequenc
mutat
function
impact
viral
infect
addit
identifi
unknown
sequenc
ng
also
map
locat
unknown
function
featur
na
epigenom
epitranscriptom
characterist
includ
interact
nucleic
acid
protein
complex
secondari
tertiari
structur
format
though
featur
thoroughli
studi
human
na
viral
na
also
fold
complex
structur
replic
andor
harbor
modif
dampen
immun
though
physic
method
crystallographi
nuclear
magnet
reson
remain
power
tool
elucid
na
form
function
chemic
enzymat
method
aid
identifi
featur
highthroughput
manner
coupl
ng
enzym
cleav
specif
na
featur
chemic
modifi
specif
base
termin
revers
transcript
produc
error
structur
region
biomark
sensit
accur
quantifi
ng
though
evalu
na
featur
pathogen
less
frequent
studi
inform
one
studi
use
ng
map
rna
structur
ebov
minigenom
identifi
trailer
noncod
region
bound
heatshock
protein
promot
minigenom
replic
better
understand
hostviru
interact
essenti
replic
could
identifi
new
target
mcm
though
live
ebov
use
studi
anoth
group
use
similar
ng
approach
virus
sindbi
viru
venezuelan
equin
enceph
viru
although
expect
genom
two
alphavirus
fold
differ
rna
structur
noteworthi
two
structur
directli
led
differ
viral
infect
addit
technolog
third
gener
sequenc
technolog
see
section
potenti
facilit
sequenc
dna
rna
base
modif
directli
distinguish
unmodifi
modifi
base
measur
chang
electr
current
asid
identifi
character
viru
genom
directli
ng
also
use
read
dna
dna
barcod
rang
function
assay
rang
larg
screen
singlemolecul
singlecel
sequenc
human
genom
scientist
develop
genomewid
protein
knockout
knockdown
eg
crispr
rna
interfer
small
hairpin
rna
small
molecul
screen
massiv
parallel
report
assay
screen
thousand
dna
simultan
exampl
research
gener
vesicular
stomat
indiana
viru
express
lasv
glycoprotein
creat
cell
randomli
knockedout
gene
use
retrovir
genetrap
vector
expos
cell
recombin
viru
identifi
host
entri
factor
lasv
ng
retrovir
insert
site
uninfect
cell
found
gene
critic
glycosyl
major
lasv
cellsurfac
receptor
also
requir
lasv
entri
infect
one
promis
technolog
start
use
virolog
singlecel
rna
sequenc
scrnaseq
scrnaseq
individu
cell
isol
uniqu
dna
barcod
appli
cell
rna
follow
ng
associ
rna
cognat
cell
homebrew
method
like
dropseq
commerci
option
like
genom
becom
increasingli
popular
scientist
profil
thousand
cell
mix
popul
peripher
blood
mononuclear
cell
pbmc
even
dissoci
tissu
research
also
use
scrnaseq
measur
heterogen
viral
replic
instanc
scientist
sequenc
singl
cell
infect
low
multipl
infect
influenza
viru
fluav
cell
contain
fluav
mrna
number
cell
fluav
read
indic
extrem
heterogen
infect
partli
attribut
variabl
fluav
replic
machineri
howev
dropseq
genom
dropletbas
requir
special
equip
platform
altern
method
microchip
microwellbas
seqwel
advantag
platform
portabl
minim
equip
requir
easili
decontamin
discard
new
techniqu
slideseq
allow
spatial
resolv
singlecel
rna
sequenc
transfer
rna
tissu
section
onto
new
surfac
cover
dnabarcod
bead
use
slideseq
cell
type
activ
state
directli
determin
use
standard
histolog
workup
seqwel
relat
technolog
could
therefor
use
laboratori
field
therebi
facilit
function
singlecel
studi
pathogen
new
wave
ng
technolog
spur
new
public
databas
bioinformat
tool
comprehens
quickli
analyz
million
short
read
thousand
long
read
pathogen
rel
rare
ng
data
gener
share
critic
us
nih
support
nation
center
biotechnolog
inform
sequenc
read
archiv
raw
sequenc
data
genbank
consensu
sequenc
human
virus
rang
databas
process
data
nih
also
support
viru
pathogen
resourc
collat
sequenc
data
experi
host
factor
assay
smaller
data
portal
like
virologicalorg
nextstrainorg
also
exist
rapidli
dissemin
prepubl
data
advanc
algorithm
comput
power
describ
chapter
book
certainli
facilit
search
classifi
process
massiv
data
set
data
requir
advanc
model
method
conjunct
basic
molecular
biolog
public
health
effort
newest
ng
technolog
often
dub
thirdgener
sequenc
driven
nanotechnolog
possess
uniqu
properti
expand
molecular
biolog
toolkit
contrast
illumina
roch
ion
torrent
shortread
methodolog
involv
cleav
genom
materi
sequencingbysynthesi
cycl
base
per
read
pacif
bioscienc
oxford
nanopor
methodolog
reli
nanoscal
pore
process
read
entir
dna
strand
produc
read
hundr
kilobas
long
though
error
rate
often
much
higher
shortread
methodolog
long
read
particularli
use
de
novo
genom
assembl
ie
assembl
unknown
genom
sequenc
reconstruct
larg
haplotyp
multipl
mutat
variant
nanoscal
pore
also
possess
uniqu
benefit
use
pacif
bioscienc
technolog
research
continu
sequenc
dna
strand
circl
creat
circular
consensu
sequenc
thu
reduc
error
rate
use
oxford
nanopor
technolog
research
sequenc
rna
directli
also
identifi
dna
rna
base
modif
addit
direct
pore
also
revers
dna
strand
read
twice
improv
consensu
sequenc
perhap
biggest
advantag
oxford
nanopor
devic
small
size
typic
resembl
usb
drive
eas
use
continu
develop
nanotechnolog
reduc
instrument
size
sampl
requir
improv
error
rate
select
ng
present
star
trekstyl
tricord
devic
univers
diagnosi
remain
unobtain
yet
holi
grail
assign
etiolog
agent
fever
unknown
origin
within
sight
mani
case
access
technolog
rather
technolog
limit
factor
pointofcar
devic
increasingli
sought
exampl
paperbas
later
flow
assay
standard
pregnanc
antibodyantigen
test
numer
isotherm
method
develop
altern
pcr
continu
improv
dnarna
test
offer
complementari
approach
detect
pathogen
ng
equip
particular
oxford
nanopor
alreadi
portabl
util
numer
outbreak
around
world
even
space
aboard
intern
space
station
accur
model
system
utmost
import
studi
normal
physiolog
pathobiolog
human
diseas
past
sever
decad
anim
model
standard
system
use
emul
human
diseas
process
convent
twodimension
vitro
system
complement
anim
model
reduc
system
complex
increas
throughput
suitabl
anim
model
yet
identifi
research
often
limit
vitro
system
howev
one
model
system
truli
capabl
reproduc
complex
biolog
process
observ
human
translat
find
anim
model
human
subject
quit
challeng
larg
biolog
differ
alter
diseas
sever
alter
suscept
pathogen
exist
human
anim
addit
convent
vitro
system
often
recreat
cellcel
interact
fail
maintain
complex
tissuetissu
organorgan
commun
critic
import
diseas
process
vivo
follow
section
highlight
use
organsonchip
organoid
model
complex
diseas
state
screen
platform
new
biomark
advantag
system
studi
infecti
diseas
therapeut
intervent
wherea
exampl
outlin
primarili
repres
work
pathogen
organsonchip
organoid
could
rel
easili
util
studi
agent
importantli
system
studi
highli
pathogen
agent
use
human
tissu
complex
dynam
set
could
close
resembl
relev
vivo
system
bridg
gap
anim
model
basic
vitro
system
advanc
microengin
microfluid
channel
creat
organonchip
technolog
organsonchip
microfluid
cellcultur
devic
fabric
use
soft
lithographi
inert
ga
permeabl
polym
biomimet
system
recreat
tissuetissu
interfac
biophys
properti
organ
includ
mechan
torsion
eg
cyclic
breath
motion
associ
expans
contract
alveolar
capillari
interfac
shear
forc
blood
flow
origin
use
recreat
lung
alveolu
organsonchip
adapt
recreat
human
small
airway
liver
intestin
kidney
bone
blood
vessel
bone
marrow
neuron
tissu
cardiac
muscl
cornea
given
flexibl
design
welldefin
architectur
wide
rang
sourc
cellular
materi
organsonchip
repres
excel
adapt
model
system
studi
wide
array
diseas
includ
chronic
obstruct
pulmonari
diseas
copd
asthma
liver
diseas
cardiovascular
diseas
malign
anoth
grow
applic
technolog
model
pathogenesi
infecti
diseas
particular
research
area
respiratori
infect
greatli
propel
use
lungonachip
small
airwayonachip
technolog
instanc
small
airwayonachip
use
model
respiratori
infect
use
tolllik
receptor
agonist
polyinosinicpolycytidyl
acid
polyic
therebi
mimick
cellular
event
viral
infect
lung
epitheli
cell
model
replic
complex
diseas
state
viral
exacerb
diseas
patient
suffer
copd
asthma
help
identifi
new
potenti
biomark
copd
exacerb
macrophag
colonystimul
factor
meanwhil
addit
lung
model
system
use
studi
fungal
bacteri
infect
lung
instanc
multicompart
human
bronchiol
creat
investig
product
inflammatori
cytokin
colon
eurotiomycet
aspergillu
fumigatu
gammaproteobacterium
pseudomona
aeruginosa
interestingli
work
show
colon
artifici
bronchiol
less
virul
fumigatu
strain
result
increas
product
inflammatori
cytokin
recruit
leukocyt
find
would
less
like
made
experi
perform
cell
monolay
vitro
moreov
inflammatori
cytokin
product
differ
bronchiol
expos
volatil
compound
produc
cocultur
p
aeruginosa
fumigatu
compar
monocultur
either
microb
describ
lungonchip
relat
model
wide
use
studi
respiratori
infect
howev
organonchip
technolog
restrict
lung
appli
studi
infect
organ
system
includ
liver
central
nervou
system
intestin
instanc
primari
human
hepatocyt
use
combin
organonchip
technolog
facil
studi
hepat
b
viru
infect
vitro
hepat
b
viru
life
cycl
host
immun
respons
eg
cytokin
respons
infect
success
model
addit
cuttingedg
microextrus
threedimension
print
techniqu
adapt
develop
nervou
systemonachip
studi
viral
infect
central
nervou
system
use
system
found
schwann
cell
refractori
pseudorabi
viru
infect
cell
still
nevertheless
particip
axontocel
spread
viru
addit
infect
human
enteroviru
coxsackieviru
success
model
use
human
gutonchip
viru
infect
replic
within
intestin
epithelium
stimul
inflammatori
cytokin
releas
polar
fashion
organonchip
system
highli
applic
bridg
gap
left
anim
vitro
model
particularli
respect
drug
discoveri
process
drug
discoveri
process
highest
lead
caus
candid
drug
attrit
clinic
trial
failur
drug
efficaci
safeti
organonchip
platform
provid
biolog
complex
environ
better
suit
convent
system
test
drug
activ
prior
clinic
trial
mimick
sever
complex
characterist
whole
organ
system
use
organsonchip
help
reduc
use
anim
model
drug
discoveri
process
would
serv
reduc
cost
drug
discoveri
process
organsonchip
clearli
advantag
model
human
infecti
diseas
howev
chip
advanc
microengin
system
suitabl
task
organoid
organ
structur
consist
organspecif
cell
grown
induc
embryon
adult
stem
cell
via
selforgan
mechan
one
advantag
organoid
capac
mimic
complex
function
natur
organ
given
structur
function
similar
natur
organ
organoid
use
extens
studi
infecti
diseas
human
sampl
human
respiratori
syncyti
viru
helicobact
pylori
hepat
c
viru
zika
viru
infect
model
use
organoid
deriv
lung
gastric
liver
nervou
system
recent
human
airway
organoid
use
screen
platform
studi
infect
emerg
fluav
fluav
strain
known
highli
infecti
human
associ
higher
replic
rate
organoid
compar
strain
known
poorli
infect
human
similar
organonchip
technolog
organoid
util
surpass
simpl
diseas
model
extens
use
drug
discoveri
process
cerebr
organoid
use
model
zika
viru
infect
identifi
potenti
therapeut
compound
abrog
damag
associ
infect
three
compound
previous
identifi
protect
effect
flaviviru
infect
oxytetracyclin
ivermectin
azithromycin
limit
zika
viru
infect
organoid
reduc
tissu
damag
suggest
compound
may
good
candid
limit
zika
viru
infect
associ
damag
vivo
overal
help
reproduc
sever
salient
featur
tissu
organ
pathophysiolog
still
room
improv
organoid
organsonchip
instanc
organoid
often
exhibit
high
variabl
size
shape
experi
natur
occur
mechan
forc
eg
breath
airflow
lung
airway
rhythmic
expansionretract
alveoli
inhalationexhal
lack
microvascular
bloodlik
flow
circul
immun
cell
continu
nutrient
oxygen
suppli
addit
accur
access
lumin
content
organoid
biochem
analysi
challeng
imposs
integr
emerg
genet
engin
tool
crisprassoci
protein
transcript
activatorlik
effector
nucleas
talen
organoid
organsonchip
would
high
valu
integr
research
introduc
new
sensit
pathogen
absent
dissect
underli
mechan
host
protect
organ
injuri
hostpathogen
interact
eg
mediat
delet
gene
propos
play
role
protect
suscept
infect
pathogen
technolog
advanc
diseas
model
includ
organsonchip
organoid
part
aim
increas
experiment
product
reduc
number
anim
requir
meet
research
goal
computationallyaid
improv
design
experi
doe
anoth
approach
potenti
improv
effici
yield
studi
although
also
significantli
reduc
burden
research
improv
effici
especi
relev
given
expens
gener
difficulti
associ
perform
research
facil
although
new
field
doe
gener
appli
chemistri
pharmaceut
develop
biolog
core
concept
recent
enhanc
machin
learn
concept
exampl
fraction
factori
doe
could
use
multivari
drug
screen
reduc
number
actual
condit
requir
measur
without
reduc
experiment
yield
techniqu
could
possibl
use
reduc
number
anim
requir
vivo
studi
inferencebas
machin
learningbas
method
drug
repurpos
improv
review
given
low
incid
pathogen
infect
drug
repurpos
import
sourc
potenti
therapeut
advanc
research
tool
describ
constantli
develop
provid
new
excit
way
investig
pathogen
opportun
defin
aspect
diseas
pathogenesi
host
respons
infect
help
teas
new
therapeut
vaccin
target
combat
diseas
howev
although
technolog
alreadi
constitut
mark
advanc
pathogen
research
use
environ
come
noteworthi
complic
laboratori
requir
yearli
mainten
minimum
replac
air
filter
perform
requir
servic
laboratori
infrastructur
compon
futurist
technolog
hous
within
laboratori
space
requir
machineri
abl
withstand
repeat
yearli
decontamin
process
eg
paraformaldehyd
gass
subsequ
neutral
microchem
plu
surfac
decontamin
laboratori
space
prepar
servic
addit
use
facil
requir
extens
train
registr
outsid
technician
gener
abil
permiss
enter
laboratori
space
servic
instrument
instrument
therefor
complex
scientist
could
troubleshoot
effect
altern
instrument
also
hous
lower
biosafeti
level
test
sampl
safe
inactiv
remov
laboratori
research
use
method
part
multipl
techniqu
includ
mani
diagnost
test
begin
inactiv
step
sampl
remov
contain
test
technolog
gener
develop
inactiv
method
mind
viral
inactiv
method
safe
handl
sampl
lower
bsl
laboratori
maintain
integr
sampl
compon
need
identifi
identif
effect
inactiv
method
test
integr
eg
sampl
dilut
signal
loss
requir
studi
addit
research
confin
control
environ
laboratori
space
deploy
technolog
outbreak
region
provid
opportun
character
human
diseas
progress
correl
diseas
outcom
without
caveat
associ
diseas
model
use
cytof
singlecel
sequenc
patient
sampl
collect
diseas
exampl
could
provid
valuabl
data
immun
respons
lead
diseas
surviv
addit
autopsi
deceas
human
infect
pathogen
rare
util
codex
mibi
could
glean
valuabl
inform
human
diseas
even
singl
autopsi
howev
outbreak
gener
occur
develop
countri
challeng
overcom
may
includ
lack
infrastructur
includ
electr
transport
andor
staf
newli
develop
technolog
need
robust
enough
counter
chang
humid
temperatur
mani
potenti
stressor
occur
outbreak
set
given
complic
futurist
technolog
describ
chapter
provid
opportun
advanc
understand
highli
pathogen
consequenti
virus
diseas
caus
